Cost effectiveness of a pragmatic exercise intervention (EXIMS) for people with multiple sclerosis: Economic evaluation of a randomised controlled trial

Multiple Sclerosis Journal

Volumn 20, Issue 8, 2014, Pages 1123-1130

  Tosh, J ^a   Dixon, S ^a   Carter, A ^b   Daley, A ^c   Petty, J ^d   Roalfe, A ^c   Sharrack, B ^e   Saxton, J M ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d Multiple Sclerosis Society ^*  (United Kingdom)

^e SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Multiple sclerosis; quality of life; rehabilitation; relapsing remitting

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC ASPECT; EXERCISE; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; ECONOMIC EVALUATION; FOLLOW UP; HOME EXERCISE; KINESIOTHERAPY; OUTCOME ASSESSMENT; PATIENT SAFETY; PRAGMATIC EXERCISE INTERVENTION; QUALITY OF LIFE; TREATMENT DURATION; COST BENEFIT ANALYSIS; ECONOMIC MODEL; ECONOMICS; ENGLAND; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TREATMENT OUTCOME;

ADULT; COST-BENEFIT ANALYSIS; ENGLAND; EXERCISE THERAPY; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; QUALITY-ADJUSTED LIFE YEARS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84904819426     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513515958     Document Type: Article

References (15)

1. Asano M, Dawes DJ, Arafah A, et al. What does a structured review of the effectiveness of exercise interventions for persons with multiple sclerosis tell us about the challenges of designing trials . Mult Scler. 2009 ; 15: 412-421
2. Motl RW, Gosney JL. Effect of exercise training on quality of life in multiple sclerosis: A meta-analysis. Mult Scler. 2008 ; 14: 129-135 (Pubitemid 351541406)
3. Rietberg MB, Brooks D, Uitdehaag BM, et al. Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev. 2005 ;: CD003980
4. Saxton JM, Carter A, Daley AJ, et al. Pragmatic exercise intervention for people with multiple sclerosis (ExIMS Trial): Study protocol for a randomised controlled trial. Contemp Clin Trials. 2012 ; 34: 205-211
5. Curtis L Unit costs of health and social care 2011. University of Kent: Personal Social Services Research Unit ; 2011 :
6. Brouwer WB, Koopmanschap MA. How to calculate indirect costs in economic evaluations. Pharmacoeconomics. 1998 ; 13 (5 Pt 1). 563-569 (Pubitemid 28239848)
7. The EuroQol Group. Health Policy. 1990 ; 16: 199-208
8. Kharroubi S, Brazier JE, O'Hagan A. Modelling covariates for the SF-6D standard gamble health state preference data using a nonparametric Bayesian method. Soc Sci Med. 2007 ; 64: 1242-1252
9. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: The role of cost-effectiveness acceptability curves. Health Econ. 2001 ; 10: 779-787 (Pubitemid 34041389)
10. van Hout BA, Al MJ, Gordon GS, et al. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ. 1994 ; 3: 309-319
11. London: National Institute for Health and Clinical Excellence ; 2008 :
12. Rubin DB Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons ; 2009 :
13. Claxton K. The irrelevance of inference: A decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999 ; 18: 341-364 (Pubitemid 29242816)
14. Drummond MF, McGuire A Economic evaluation in healthcare: Merging theory with practice. New York: Oxford University Press Inc ; 2001 :
15. Glick HA, Doshi JA, Sonnad SS, et al Economic evaluation in clinical trials. New York: Oxford University Press Inc ; 2013 :